Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445144 · ClinicalTrials.gov registry record
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Terminated
- Registry status
- 26
- Enrollment target
NCT02445144 is a clinical trial that was terminated before completion, run by Albert Einstein College of Medicine. The registered enrollment target is 26 participants.
The verdict
NCT02445144 was terminated before completion, sponsored by Albert Einstein College of Medicine.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Patients with sickle cell anemia (SCA) are at an increased risk for damage to brain tissue due to their disease. The investigators are interested in how blood flow and cerebral inflammation are different in SCA patients and how that affects brain tissue- the investigators will use a relatively new set of dynamic MRI techniques to evaluate these parameters. The investigators will image participants with both SCA and matched controls with non-invasive MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-11 |
| Est. Completion | 2020-05-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02445144
The ClinicalTrials.gov registry entry for NCT02445144 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02445144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02445144 about?
NCT02445144 is a clinical study titled "Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease". Patients with sickle cell anemia (SCA) are at an increased risk for damage to brain tissue due to their disease. The investigators are interested in how blood flow and cerebral inflammation are different in SCA patients and how that affects brain tissue- the investigators will use a relatively new s...
What is the current status of trial NCT02445144?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2014-11. Estimated completion is 2020-05-04.
Who is sponsoring clinical trial NCT02445144?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.